Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
European Journal of Medicinal Chemistry|October 18, 2011
Design, synthesis and biological study of novel pyrido[2,3-d]pyrimidine as anti-proliferative CDK2 inhibitorsDiaa A Ibrahim, Nasser S M Ismail
European Journal of Medicinal Chemistry|April 15, 2011
Facile synthesis, vasorelaxant properties and molecular modeling studies of 2-amino-8a-methoxy-4H-pyrano[3,2-c]pyridine-3-carbonitrilesAdel S Girgis, Nasser S M Ismail, Hanaa Farag
European Journal of Medicinal Chemistry|November 29, 2011
Synthesis and QSAR study of novel cytotoxic spiro[3H-indole-3,2'(1'H)-pyrrolo[3,4-c]pyrrole]-2,3',5'(1H,2'aH,4'H)-trionesAdel S Girgis, Jacek Stawinski, Nasser S M Ismail, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 3, 2012
Molecular modeling study bioactive natural product of khellin analogues as a novel potential pharmacophore of EGFR inhibitorsAbdel-Sattar S Hamad Elgazwy, Mastoura M Edrees, Nasser S M Ismail
European Journal of Medicinal Chemistry|September 3, 2013
Design, synthesis and QSAR studies of dispiroindole derivatives as new antiproliferative agentsRiham F George, Nasser S M Ismail, Jacek Stawinski, et al.
Archiv Der Pharmazie|October 14, 2017
Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer ActivitiesAmna Ghith, Nasser S M Ismail, Khairia Youssef, et al.
European Journal of Medicinal Chemistry|August 30, 2011
Synthesis, hypnotic properties and molecular modeling studies of 1,2,7,9-tetraaza-spiro[4.5]dec-2-ene-6,8,10-trionesAdel S Girgis, Hanaa Farag, Nasser S M Ismail, et al.
Bioorganic Chemistry|October 22, 2018
Design, synthesis and molecular modeling study of certain VEGFR-2 inhibitors based on thienopyrimidne scaffold as cancer targeting agentsAmna Ghith, Khairia M Youssef, Nasser S M Ismail, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 16, 2020
A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infectionYasmin Abo-Zeid, Nasser S M Ismail, Gary R McLean, et al.
Pageof 5